nodes	percent_of_prediction	percent_of_DWPC	metapath
Methamphetamine—SLC6A4—migraine	0.393	1	CbGaD
Methamphetamine—SLC6A4—Amitriptyline—migraine	0.0653	0.16	CbGbCtD
Methamphetamine—SLC22A5—Valproic Acid—migraine	0.0624	0.153	CbGbCtD
Methamphetamine—SLC6A2—Amitriptyline—migraine	0.0546	0.134	CbGbCtD
Methamphetamine—SLC22A5—Verapamil—migraine	0.0543	0.133	CbGbCtD
Methamphetamine—SLC6A4—Verapamil—migraine	0.0518	0.127	CbGbCtD
Methamphetamine—ADRA2A—Amitriptyline—migraine	0.0492	0.121	CbGbCtD
Methamphetamine—CYP2D6—Timolol—migraine	0.0212	0.0522	CbGbCtD
Methamphetamine—CYP2D6—Propranolol—migraine	0.0189	0.0465	CbGbCtD
Methamphetamine—CYP2D6—Amitriptyline—migraine	0.0164	0.0402	CbGbCtD
Methamphetamine—CYP2D6—Verapamil—migraine	0.013	0.0319	CbGbCtD
Methamphetamine—SLC6A2—locus ceruleus—migraine	0.0042	0.0779	CbGeAlD
Methamphetamine—MAOA—locus ceruleus—migraine	0.00387	0.0717	CbGeAlD
Methamphetamine—TAAR1—neck—migraine	0.0034	0.063	CbGeAlD
Methamphetamine—SLC6A2—sympathetic nervous system—migraine	0.00332	0.0615	CbGeAlD
Methamphetamine—SLC6A2—autonomic nervous system—migraine	0.00223	0.0414	CbGeAlD
Methamphetamine—SLC6A3—nerve—migraine	0.00156	0.0288	CbGeAlD
Methamphetamine—Phenacemide—SCN1A—migraine	0.00156	0.319	CrCbGaD
Methamphetamine—SLC18A1—head—migraine	0.00153	0.0283	CbGeAlD
Methamphetamine—SLC18A1—nervous system—migraine	0.00145	0.0268	CbGeAlD
Methamphetamine—SLC18A1—central nervous system—migraine	0.00139	0.0258	CbGeAlD
Methamphetamine—Erectile dysfunction—Amitriptyline—migraine	0.00137	0.0289	CcSEcCtD
Methamphetamine—TAAR1—nervous system—migraine	0.00136	0.0252	CbGeAlD
Methamphetamine—MAOB—nerve—migraine	0.00136	0.0251	CbGeAlD
Methamphetamine—TAAR1—central nervous system—migraine	0.00131	0.0243	CbGeAlD
Methamphetamine—Psychotic disorder—Verapamil—migraine	0.00126	0.0266	CcSEcCtD
Methamphetamine—SLC6A2—nerve—migraine	0.00126	0.0233	CbGeAlD
Methamphetamine—Dexfenfluramine—HTR2B—migraine	0.00125	0.257	CrCbGaD
Methamphetamine—MAOA—nerve—migraine	0.00116	0.0214	CbGeAlD
Methamphetamine—ADRA2A—peripheral nervous system—migraine	0.00114	0.0211	CbGeAlD
Methamphetamine—Erectile dysfunction—Propranolol—migraine	0.00112	0.0236	CcSEcCtD
Methamphetamine—SLC18A1—brain—migraine	0.00111	0.0205	CbGeAlD
Methamphetamine—Euphoric mood—Valproic Acid—migraine	0.00108	0.0229	CcSEcCtD
Methamphetamine—Erectile dysfunction—Verapamil—migraine	0.00103	0.0217	CcSEcCtD
Methamphetamine—Tremor—Amitriptyline—migraine	0.000974	0.0205	CcSEcCtD
Methamphetamine—Agitation—Amitriptyline—migraine	0.000955	0.0201	CcSEcCtD
Methamphetamine—Palpitations—Amitriptyline—migraine	0.000918	0.0194	CcSEcCtD
Methamphetamine—Euphoric mood—Gabapentin—migraine	0.000899	0.019	CcSEcCtD
Methamphetamine—Psychotic disorder—Valproic Acid—migraine	0.000895	0.0189	CcSEcCtD
Methamphetamine—SLC18A2—brainstem—migraine	0.000883	0.0164	CbGeAlD
Methamphetamine—Tachycardia—Amitriptyline—migraine	0.000828	0.0174	CcSEcCtD
Methamphetamine—Agitation—Propranolol—migraine	0.000777	0.0164	CcSEcCtD
Methamphetamine—Insomnia—Amitriptyline—migraine	0.000767	0.0162	CcSEcCtD
Methamphetamine—Euphoric mood—Topiramate—migraine	0.000756	0.0159	CcSEcCtD
Methamphetamine—Dyspepsia—Amitriptyline—migraine	0.000746	0.0157	CcSEcCtD
Methamphetamine—Psychotic disorder—Gabapentin—migraine	0.000742	0.0156	CcSEcCtD
Methamphetamine—Tremor—Verapamil—migraine	0.000729	0.0154	CcSEcCtD
Methamphetamine—Constipation—Amitriptyline—migraine	0.000725	0.0153	CcSEcCtD
Methamphetamine—Agitation—Verapamil—migraine	0.000715	0.0151	CcSEcCtD
Methamphetamine—SLC22A3—trigeminal ganglion—migraine	0.000711	0.0132	CbGeAlD
Methamphetamine—Palpitations—Verapamil—migraine	0.000688	0.0145	CcSEcCtD
Methamphetamine—Urticaria—Amitriptyline—migraine	0.000674	0.0142	CcSEcCtD
Methamphetamine—SLC6A3—brainstem—migraine	0.000668	0.0124	CbGeAlD
Methamphetamine—MAOB—trigeminal ganglion—migraine	0.000658	0.0122	CbGeAlD
Methamphetamine—MAOA—neck—migraine	0.00065	0.012	CbGeAlD
Methamphetamine—Erectile dysfunction—Timolol—migraine	0.000649	0.0137	CcSEcCtD
Methamphetamine—Insomnia—Propranolol—migraine	0.000625	0.0132	CcSEcCtD
Methamphetamine—Psychotic disorder—Topiramate—migraine	0.000624	0.0132	CcSEcCtD
Methamphetamine—Tachycardia—Verapamil—migraine	0.00062	0.0131	CcSEcCtD
Methamphetamine—Dexfenfluramine—HTR2C—migraine	0.000613	0.126	CrCbGaD
Methamphetamine—SLC6A4—brainstem—migraine	0.000612	0.0113	CbGeAlD
Methamphetamine—Dyspepsia—Propranolol—migraine	0.000608	0.0128	CcSEcCtD
Methamphetamine—Erectile dysfunction—Gabapentin—migraine	0.000605	0.0127	CcSEcCtD
Methamphetamine—Gastrointestinal disorder—Propranolol—migraine	0.000596	0.0126	CcSEcCtD
Methamphetamine—Constipation—Propranolol—migraine	0.00059	0.0124	CcSEcCtD
Methamphetamine—MAOB—brainstem—migraine	0.000582	0.0108	CbGeAlD
Methamphetamine—Diarrhoea—Amitriptyline—migraine	0.00058	0.0122	CcSEcCtD
Methamphetamine—Insomnia—Verapamil—migraine	0.000574	0.0121	CcSEcCtD
Methamphetamine—MAOA—trigeminal ganglion—migraine	0.000561	0.0104	CbGeAlD
Methamphetamine—Dizziness—Amitriptyline—migraine	0.000561	0.0118	CcSEcCtD
Methamphetamine—Dyspepsia—Verapamil—migraine	0.000559	0.0118	CcSEcCtD
Methamphetamine—Urticaria—Propranolol—migraine	0.000549	0.0116	CcSEcCtD
Methamphetamine—Constipation—Verapamil—migraine	0.000543	0.0114	CcSEcCtD
Methamphetamine—ADRA2C—trigeminal ganglion—migraine	0.00054	0.01	CbGeAlD
Methamphetamine—SLC6A2—brainstem—migraine	0.000539	0.00999	CbGeAlD
Methamphetamine—Headache—Amitriptyline—migraine	0.000531	0.0112	CcSEcCtD
Methamphetamine—Tremor—Valproic Acid—migraine	0.000517	0.0109	CcSEcCtD
Methamphetamine—SLC22A5—trigeminal ganglion—migraine	0.000517	0.00958	CbGeAlD
Methamphetamine—Hypersensitivity—Propranolol—migraine	0.000509	0.0107	CcSEcCtD
Methamphetamine—Erectile dysfunction—Topiramate—migraine	0.000509	0.0107	CcSEcCtD
Methamphetamine—Dexfenfluramine—SLC6A4—migraine	0.000508	0.104	CrCbGaD
Methamphetamine—Agitation—Valproic Acid—migraine	0.000507	0.0107	CcSEcCtD
Methamphetamine—Urticaria—Verapamil—migraine	0.000505	0.0106	CcSEcCtD
Methamphetamine—MAOA—brainstem—migraine	0.000497	0.0092	CbGeAlD
Methamphetamine—SLC18A2—head—migraine	0.000488	0.00905	CbGeAlD
Methamphetamine—Palpitations—Valproic Acid—migraine	0.000488	0.0103	CcSEcCtD
Methamphetamine—MAOB—cardiovascular system—migraine	0.000475	0.0088	CbGeAlD
Methamphetamine—Diarrhoea—Propranolol—migraine	0.000472	0.00996	CcSEcCtD
Methamphetamine—Hypersensitivity—Verapamil—migraine	0.000468	0.00986	CcSEcCtD
Methamphetamine—SLC18A2—nervous system—migraine	0.000463	0.00858	CbGeAlD
Methamphetamine—Dizziness—Propranolol—migraine	0.000457	0.00962	CcSEcCtD
Methamphetamine—SLC18A2—central nervous system—migraine	0.000446	0.00826	CbGeAlD
Methamphetamine—Tachycardia—Valproic Acid—migraine	0.00044	0.00926	CcSEcCtD
Methamphetamine—SLC18A2—cerebellum—migraine	0.000436	0.00807	CbGeAlD
Methamphetamine—Diarrhoea—Verapamil—migraine	0.000435	0.00916	CcSEcCtD
Methamphetamine—Palpitations—Timolol—migraine	0.000434	0.00915	CcSEcCtD
Methamphetamine—ADRA2A—trigeminal ganglion—migraine	0.000431	0.00798	CbGeAlD
Methamphetamine—Tremor—Gabapentin—migraine	0.000429	0.00903	CcSEcCtD
Methamphetamine—Agitation—Gabapentin—migraine	0.00042	0.00886	CcSEcCtD
Methamphetamine—Dizziness—Verapamil—migraine	0.00042	0.00885	CcSEcCtD
Methamphetamine—Insomnia—Valproic Acid—migraine	0.000407	0.00859	CcSEcCtD
Methamphetamine—MAOA—cardiovascular system—migraine	0.000405	0.00751	CbGeAlD
Methamphetamine—Palpitations—Gabapentin—migraine	0.000404	0.00852	CcSEcCtD
Methamphetamine—Headache—Verapamil—migraine	0.000398	0.00839	CcSEcCtD
Methamphetamine—Dyspepsia—Valproic Acid—migraine	0.000396	0.00836	CcSEcCtD
Methamphetamine—Gastrointestinal disorder—Valproic Acid—migraine	0.000389	0.00819	CcSEcCtD
Methamphetamine—Constipation—Valproic Acid—migraine	0.000385	0.00812	CcSEcCtD
Methamphetamine—SLC6A3—head—migraine	0.000369	0.00684	CbGeAlD
Methamphetamine—Tachycardia—Gabapentin—migraine	0.000364	0.00768	CcSEcCtD
Methamphetamine—Insomnia—Timolol—migraine	0.000363	0.00764	CcSEcCtD
Methamphetamine—Tremor—Topiramate—migraine	0.000361	0.0076	CcSEcCtD
Methamphetamine—Urticaria—Valproic Acid—migraine	0.000358	0.00754	CcSEcCtD
Methamphetamine—SLC18A2—brain—migraine	0.000354	0.00656	CbGeAlD
Methamphetamine—Agitation—Topiramate—migraine	0.000354	0.00745	CcSEcCtD
Methamphetamine—Dyspepsia—Timolol—migraine	0.000353	0.00744	CcSEcCtD
Methamphetamine—SLC6A3—nervous system—migraine	0.00035	0.00649	CbGeAlD
Methamphetamine—SLC22A3—head—migraine	0.000348	0.00644	CbGeAlD
Methamphetamine—Gastrointestinal disorder—Timolol—migraine	0.000346	0.0073	CcSEcCtD
Methamphetamine—Palpitations—Topiramate—migraine	0.00034	0.00717	CcSEcCtD
Methamphetamine—SLC6A4—head—migraine	0.000338	0.00627	CbGeAlD
Methamphetamine—Insomnia—Gabapentin—migraine	0.000338	0.00712	CcSEcCtD
Methamphetamine—SLC6A3—central nervous system—migraine	0.000337	0.00625	CbGeAlD
Methamphetamine—Hypersensitivity—Valproic Acid—migraine	0.000332	0.00699	CcSEcCtD
Methamphetamine—SLC22A3—nervous system—migraine	0.00033	0.00611	CbGeAlD
Methamphetamine—SLC6A3—cerebellum—migraine	0.000329	0.0061	CbGeAlD
Methamphetamine—Dyspepsia—Gabapentin—migraine	0.000329	0.00693	CcSEcCtD
Methamphetamine—Gastrointestinal disorder—Gabapentin—migraine	0.000322	0.00679	CcSEcCtD
Methamphetamine—MAOB—head—migraine	0.000322	0.00596	CbGeAlD
Methamphetamine—SLC6A4—nervous system—migraine	0.000321	0.00594	CbGeAlD
Methamphetamine—Constipation—Gabapentin—migraine	0.000319	0.00673	CcSEcCtD
Methamphetamine—Urticaria—Timolol—migraine	0.000318	0.00671	CcSEcCtD
Methamphetamine—SLC22A3—central nervous system—migraine	0.000317	0.00588	CbGeAlD
Methamphetamine—SLC6A4—central nervous system—migraine	0.000309	0.00572	CbGeAlD
Methamphetamine—Diarrhoea—Valproic Acid—migraine	0.000308	0.00649	CcSEcCtD
Methamphetamine—Tachycardia—Topiramate—migraine	0.000307	0.00646	CcSEcCtD
Methamphetamine—MAOB—nervous system—migraine	0.000305	0.00565	CbGeAlD
Methamphetamine—SLC6A2—head—migraine	0.000298	0.00552	CbGeAlD
Methamphetamine—Dizziness—Valproic Acid—migraine	0.000298	0.00628	CcSEcCtD
Methamphetamine—Urticaria—Gabapentin—migraine	0.000297	0.00625	CcSEcCtD
Methamphetamine—Hypersensitivity—Timolol—migraine	0.000295	0.00623	CcSEcCtD
Methamphetamine—CYP2D6—brainstem—migraine	0.000295	0.00547	CbGeAlD
Methamphetamine—MAOB—central nervous system—migraine	0.000294	0.00544	CbGeAlD
Methamphetamine—Pseudoephedrine—TNF—migraine	0.000288	0.059	CrCbGaD
Methamphetamine—MAOB—cerebellum—migraine	0.000287	0.00532	CbGeAlD
Methamphetamine—Insomnia—Topiramate—migraine	0.000284	0.00599	CcSEcCtD
Methamphetamine—SLC6A2—nervous system—migraine	0.000282	0.00523	CbGeAlD
Methamphetamine—Headache—Valproic Acid—migraine	0.000282	0.00595	CcSEcCtD
Methamphetamine—Dyspepsia—Topiramate—migraine	0.000276	0.00583	CcSEcCtD
Methamphetamine—Hypersensitivity—Gabapentin—migraine	0.000275	0.0058	CcSEcCtD
Methamphetamine—MAOA—head—migraine	0.000275	0.00509	CbGeAlD
Methamphetamine—Diarrhoea—Timolol—migraine	0.000274	0.00578	CcSEcCtD
Methamphetamine—SLC6A2—central nervous system—migraine	0.000272	0.00504	CbGeAlD
Methamphetamine—Gastrointestinal disorder—Topiramate—migraine	0.000271	0.00572	CcSEcCtD
Methamphetamine—Constipation—Topiramate—migraine	0.000269	0.00566	CcSEcCtD
Methamphetamine—SLC6A3—brain—migraine	0.000268	0.00496	CbGeAlD
Methamphetamine—Dizziness—Timolol—migraine	0.000265	0.00559	CcSEcCtD
Methamphetamine—ADRA2C—head—migraine	0.000264	0.00489	CbGeAlD
Methamphetamine—MAOA—nervous system—migraine	0.00026	0.00482	CbGeAlD
Methamphetamine—Diarrhoea—Gabapentin—migraine	0.000255	0.00538	CcSEcCtD
Methamphetamine—SLC22A3—brain—migraine	0.000252	0.00467	CbGeAlD
Methamphetamine—Headache—Timolol—migraine	0.000251	0.00529	CcSEcCtD
Methamphetamine—MAOA—central nervous system—migraine	0.000251	0.00464	CbGeAlD
Methamphetamine—ADRA2C—nervous system—migraine	0.00025	0.00464	CbGeAlD
Methamphetamine—Urticaria—Topiramate—migraine	0.00025	0.00526	CcSEcCtD
Methamphetamine—Dizziness—Gabapentin—migraine	0.000247	0.0052	CcSEcCtD
Methamphetamine—SLC6A4—brain—migraine	0.000245	0.00454	CbGeAlD
Methamphetamine—MAOA—cerebellum—migraine	0.000245	0.00454	CbGeAlD
Methamphetamine—Phentermine—SLC6A4—migraine	0.000244	0.0501	CrCbGaD
Methamphetamine—ADRA2C—central nervous system—migraine	0.000241	0.00446	CbGeAlD
Methamphetamine—ADRA2C—cerebellum—migraine	0.000235	0.00436	CbGeAlD
Methamphetamine—Headache—Gabapentin—migraine	0.000234	0.00493	CcSEcCtD
Methamphetamine—MAOB—brain—migraine	0.000233	0.00432	CbGeAlD
Methamphetamine—Pseudoephedrine—SLC6A4—migraine	0.000232	0.0475	CrCbGaD
Methamphetamine—Hypersensitivity—Topiramate—migraine	0.000231	0.00488	CcSEcCtD
Methamphetamine—SLC22A5—cerebellum—migraine	0.000226	0.00418	CbGeAlD
Methamphetamine—SLC6A2—brain—migraine	0.000216	0.004	CbGeAlD
Methamphetamine—Diarrhoea—Topiramate—migraine	0.000215	0.00453	CcSEcCtD
Methamphetamine—ADRA2A—head—migraine	0.000211	0.0039	CbGeAlD
Methamphetamine—Dizziness—Topiramate—migraine	0.000208	0.00438	CcSEcCtD
Methamphetamine—ADRA2A—nervous system—migraine	0.0002	0.0037	CbGeAlD
Methamphetamine—MAOA—brain—migraine	0.000199	0.00369	CbGeAlD
Methamphetamine—Headache—Topiramate—migraine	0.000197	0.00415	CcSEcCtD
Methamphetamine—ADRA2A—central nervous system—migraine	0.000192	0.00356	CbGeAlD
Methamphetamine—ADRA2C—brain—migraine	0.000191	0.00354	CbGeAlD
Methamphetamine—Amphetamine—SLC6A4—migraine	0.000188	0.0385	CrCbGaD
Methamphetamine—ADRA2A—cerebellum—migraine	0.000188	0.00348	CbGeAlD
Methamphetamine—SLC22A5—brain—migraine	0.000183	0.00339	CbGeAlD
Methamphetamine—CYP2D6—head—migraine	0.000163	0.00302	CbGeAlD
Methamphetamine—CYP2D6—nervous system—migraine	0.000155	0.00287	CbGeAlD
Methamphetamine—ADRA2A—brain—migraine	0.000153	0.00283	CbGeAlD
Methamphetamine—CYP2D6—central nervous system—migraine	0.000149	0.00276	CbGeAlD
Methamphetamine—CYP2D6—cerebellum—migraine	0.000146	0.0027	CbGeAlD
Methamphetamine—CYP2D6—brain—migraine	0.000118	0.00219	CbGeAlD
Methamphetamine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—HTR1D—migraine	0.000106	0.00114	CbGpPWpGaD
Methamphetamine—TAAR1—Signaling by GPCR—CALCA—migraine	0.000105	0.00112	CbGpPWpGaD
Methamphetamine—ADRA2B—G alpha (i) signalling events—HTR1A—migraine	0.000103	0.0011	CbGpPWpGaD
Methamphetamine—ADRA2C—G alpha (i) signalling events—HTR1B—migraine	9.98e-05	0.00107	CbGpPWpGaD
Methamphetamine—ADRA2C—GPCR ligand binding—HTR1D—migraine	9.97e-05	0.00107	CbGpPWpGaD
Methamphetamine—ADRA2B—GPCR ligand binding—HTR2B—migraine	9.93e-05	0.00106	CbGpPWpGaD
Methamphetamine—ADRA2B—GPCRs, Class A Rhodopsin-like—HTR1B—migraine	9.91e-05	0.00106	CbGpPWpGaD
Methamphetamine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—HTR2B—migraine	9.89e-05	0.00106	CbGpPWpGaD
Methamphetamine—TAAR1—Signaling by GPCR—HTR7—migraine	9.82e-05	0.00105	CbGpPWpGaD
Methamphetamine—TAAR1—Signaling Pathways—LRP1—migraine	9.63e-05	0.00103	CbGpPWpGaD
Methamphetamine—ADRA2C—G alpha (i) signalling events—HTR1A—migraine	9.61e-05	0.00103	CbGpPWpGaD
Methamphetamine—MAOA—SIDS Susceptibility Pathways—HTR2A—migraine	9.6e-05	0.00103	CbGpPWpGaD
Methamphetamine—ADRA2B—GPCRs, Class A Rhodopsin-like—HTR1A—migraine	9.54e-05	0.00102	CbGpPWpGaD
Methamphetamine—ADRA2C—GPCR ligand binding—HTR2B—migraine	9.27e-05	0.000991	CbGpPWpGaD
Methamphetamine—ADRA2C—GPCRs, Class A Rhodopsin-like—HTR1B—migraine	9.26e-05	0.00099	CbGpPWpGaD
Methamphetamine—ADRA2B—GPCRs, Class A Rhodopsin-like—HTR2C—migraine	9.22e-05	0.000985	CbGpPWpGaD
Methamphetamine—ADRA2B—GPCRs, Class A Rhodopsin-like—EDNRA—migraine	8.97e-05	0.000959	CbGpPWpGaD
Methamphetamine—ADRA2C—GPCRs, Class A Rhodopsin-like—HTR1A—migraine	8.91e-05	0.000953	CbGpPWpGaD
Methamphetamine—ADRA2C—GPCRs, Class A Rhodopsin-like—HTR2C—migraine	8.61e-05	0.00092	CbGpPWpGaD
Methamphetamine—ADRA2B—Class A/1 (Rhodopsin-like receptors)—HTR1B—migraine	8.49e-05	0.000908	CbGpPWpGaD
Methamphetamine—ADRA2C—GPCRs, Class A Rhodopsin-like—EDNRA—migraine	8.38e-05	0.000895	CbGpPWpGaD
Methamphetamine—ADRA2B—GPCR downstream signaling—RAMP1—migraine	8.3e-05	0.000888	CbGpPWpGaD
Methamphetamine—ADRA2B—GPCR downstream signaling—CALCRL—migraine	8.3e-05	0.000888	CbGpPWpGaD
Methamphetamine—ADRA2B—Class A/1 (Rhodopsin-like receptors)—HTR1A—migraine	8.18e-05	0.000874	CbGpPWpGaD
Methamphetamine—ADRA2A—G alpha (i) signalling events—HTR1B—migraine	8.11e-05	0.000867	CbGpPWpGaD
Methamphetamine—ADRA2A—GPCR ligand binding—HTR1D—migraine	8.1e-05	0.000866	CbGpPWpGaD
Methamphetamine—ADRA2B—GPCRs, Class A Rhodopsin-like—HTR7—migraine	8.07e-05	0.000863	CbGpPWpGaD
Methamphetamine—ADRA2B—Class A/1 (Rhodopsin-like receptors)—NPS—migraine	8.05e-05	0.000861	CbGpPWpGaD
Methamphetamine—ADRA2B—Class A/1 (Rhodopsin-like receptors)—TAC1—migraine	8.05e-05	0.000861	CbGpPWpGaD
Methamphetamine—ADRA2C—Class A/1 (Rhodopsin-like receptors)—HTR1B—migraine	7.93e-05	0.000848	CbGpPWpGaD
Methamphetamine—ADRA2B—Class A/1 (Rhodopsin-like receptors)—HTR2C—migraine	7.9e-05	0.000844	CbGpPWpGaD
Methamphetamine—ADRA2A—G alpha (i) signalling events—HTR1A—migraine	7.8e-05	0.000834	CbGpPWpGaD
Methamphetamine—ADRA2C—GPCR downstream signaling—RAMP1—migraine	7.76e-05	0.000829	CbGpPWpGaD
Methamphetamine—ADRA2C—GPCR downstream signaling—CALCRL—migraine	7.76e-05	0.000829	CbGpPWpGaD
Methamphetamine—ADRA2B—Class A/1 (Rhodopsin-like receptors)—EDNRA—migraine	7.68e-05	0.000821	CbGpPWpGaD
Methamphetamine—ADRA2C—Class A/1 (Rhodopsin-like receptors)—HTR1A—migraine	7.64e-05	0.000817	CbGpPWpGaD
Methamphetamine—TAAR1—GPCR downstream signaling—HTR2A—migraine	7.58e-05	0.00081	CbGpPWpGaD
Methamphetamine—ADRA2C—GPCRs, Class A Rhodopsin-like—HTR7—migraine	7.54e-05	0.000806	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling by GPCR—CALCRL—migraine	7.54e-05	0.000806	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling by GPCR—RAMP1—migraine	7.54e-05	0.000806	CbGpPWpGaD
Methamphetamine—ADRA2A—GPCR ligand binding—HTR2B—migraine	7.53e-05	0.000805	CbGpPWpGaD
Methamphetamine—ADRA2A—GPCRs, Class A Rhodopsin-like—HTR1B—migraine	7.52e-05	0.000804	CbGpPWpGaD
Methamphetamine—ADRA2C—Class A/1 (Rhodopsin-like receptors)—NPS—migraine	7.52e-05	0.000804	CbGpPWpGaD
Methamphetamine—ADRA2C—Class A/1 (Rhodopsin-like receptors)—TAC1—migraine	7.52e-05	0.000804	CbGpPWpGaD
Methamphetamine—TAAR1—Signaling Pathways—NOTCH4—migraine	7.39e-05	0.00079	CbGpPWpGaD
Methamphetamine—ADRA2C—Class A/1 (Rhodopsin-like receptors)—HTR2C—migraine	7.38e-05	0.000789	CbGpPWpGaD
Methamphetamine—MAOB—Metabolism—CACNA1A—migraine	7.31e-05	0.000781	CbGpPWpGaD
Methamphetamine—ADRA2A—GPCRs, Class A Rhodopsin-like—HTR1A—migraine	7.24e-05	0.000774	CbGpPWpGaD
Methamphetamine—ADRA2C—Class A/1 (Rhodopsin-like receptors)—EDNRA—migraine	7.18e-05	0.000767	CbGpPWpGaD
Methamphetamine—TAAR1—Signaling Pathways—HTR1B—migraine	7.13e-05	0.000762	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling by GPCR—RAMP1—migraine	7.04e-05	0.000753	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling by GPCR—CALCRL—migraine	7.04e-05	0.000753	CbGpPWpGaD
Methamphetamine—ADRA2A—GPCRs, Class A Rhodopsin-like—HTR2C—migraine	6.99e-05	0.000748	CbGpPWpGaD
Methamphetamine—ADRA2B—Class A/1 (Rhodopsin-like receptors)—HTR7—migraine	6.92e-05	0.000739	CbGpPWpGaD
Methamphetamine—TAAR1—Signaling by GPCR—HTR2A—migraine	6.88e-05	0.000736	CbGpPWpGaD
Methamphetamine—TAAR1—Signaling Pathways—HTR1A—migraine	6.86e-05	0.000733	CbGpPWpGaD
Methamphetamine—ADRA2A—GPCRs, Class A Rhodopsin-like—EDNRA—migraine	6.8e-05	0.000727	CbGpPWpGaD
Methamphetamine—TAAR1—Signaling Pathways—TAC1—migraine	6.76e-05	0.000722	CbGpPWpGaD
Methamphetamine—TAAR1—Signaling Pathways—PGR—migraine	6.76e-05	0.000722	CbGpPWpGaD
Methamphetamine—TAAR1—Signaling Pathways—NPS—migraine	6.76e-05	0.000722	CbGpPWpGaD
Methamphetamine—TAAR1—Signaling Pathways—HTR2C—migraine	6.63e-05	0.000708	CbGpPWpGaD
Methamphetamine—ADRA2B—GPCR ligand binding—HTR1B—migraine	6.47e-05	0.000692	CbGpPWpGaD
Methamphetamine—ADRA2C—Class A/1 (Rhodopsin-like receptors)—HTR7—migraine	6.46e-05	0.000691	CbGpPWpGaD
Methamphetamine—TAAR1—Signaling Pathways—EDNRA—migraine	6.44e-05	0.000689	CbGpPWpGaD
Methamphetamine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—HTR1B—migraine	6.44e-05	0.000689	CbGpPWpGaD
Methamphetamine—ADRA2A—GPCR downstream signaling—RAMP1—migraine	6.3e-05	0.000674	CbGpPWpGaD
Methamphetamine—ADRA2A—GPCR downstream signaling—CALCRL—migraine	6.3e-05	0.000674	CbGpPWpGaD
Methamphetamine—TAAR1—Signaling Pathways—NOTCH3—migraine	6.28e-05	0.000671	CbGpPWpGaD
Methamphetamine—ADRA2B—GPCR ligand binding—HTR1A—migraine	6.23e-05	0.000666	CbGpPWpGaD
Methamphetamine—TAAR1—Signaling Pathways—CALCA—migraine	6.2e-05	0.000663	CbGpPWpGaD
Methamphetamine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—HTR1A—migraine	6.2e-05	0.000663	CbGpPWpGaD
Methamphetamine—SLC22A3—Metabolism—CACNA1A—migraine	6.18e-05	0.000661	CbGpPWpGaD
Methamphetamine—ADRA2B—GPCR ligand binding—TAC1—migraine	6.13e-05	0.000656	CbGpPWpGaD
Methamphetamine—ADRA2B—GPCR ligand binding—NPS—migraine	6.13e-05	0.000656	CbGpPWpGaD
Methamphetamine—ADRA2A—GPCRs, Class A Rhodopsin-like—HTR7—migraine	6.12e-05	0.000655	CbGpPWpGaD
Methamphetamine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—TAC1—migraine	6.11e-05	0.000653	CbGpPWpGaD
Methamphetamine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—NPS—migraine	6.11e-05	0.000653	CbGpPWpGaD
Methamphetamine—ADRA2C—GPCR ligand binding—HTR1B—migraine	6.04e-05	0.000646	CbGpPWpGaD
Methamphetamine—ADRA2B—GPCR downstream signaling—HTR1D—migraine	6.03e-05	0.000645	CbGpPWpGaD
Methamphetamine—ADRA2B—GPCR ligand binding—HTR2C—migraine	6.01e-05	0.000643	CbGpPWpGaD
Methamphetamine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—HTR2C—migraine	5.99e-05	0.000641	CbGpPWpGaD
Methamphetamine—ADRA2B—GPCR ligand binding—EDNRA—migraine	5.85e-05	0.000625	CbGpPWpGaD
Methamphetamine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—EDNRA—migraine	5.83e-05	0.000623	CbGpPWpGaD
Methamphetamine—ADRA2C—GPCR ligand binding—HTR1A—migraine	5.82e-05	0.000622	CbGpPWpGaD
Methamphetamine—TAAR1—Signaling Pathways—HTR7—migraine	5.8e-05	0.00062	CbGpPWpGaD
Methamphetamine—ADRA2C—GPCR ligand binding—TAC1—migraine	5.73e-05	0.000612	CbGpPWpGaD
Methamphetamine—ADRA2C—GPCR ligand binding—NPS—migraine	5.73e-05	0.000612	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—RAMP1—migraine	5.72e-05	0.000612	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—CALCRL—migraine	5.72e-05	0.000612	CbGpPWpGaD
Methamphetamine—ADRA2B—GPCRs, Class A Rhodopsin-like—HTR2A—migraine	5.65e-05	0.000605	CbGpPWpGaD
Methamphetamine—ADRA2C—GPCR downstream signaling—HTR1D—migraine	5.64e-05	0.000603	CbGpPWpGaD
Methamphetamine—ADRA2B—GPCR ligand binding—CALCA—migraine	5.63e-05	0.000602	CbGpPWpGaD
Methamphetamine—ADRA2C—GPCR ligand binding—HTR2C—migraine	5.62e-05	0.000601	CbGpPWpGaD
Methamphetamine—ADRA2B—GPCR downstream signaling—HTR2B—migraine	5.61e-05	0.0006	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling by GPCR—HTR1D—migraine	5.48e-05	0.000586	CbGpPWpGaD
Methamphetamine—ADRA2C—GPCR ligand binding—EDNRA—migraine	5.46e-05	0.000584	CbGpPWpGaD
Methamphetamine—ADRA2C—GPCRs, Class A Rhodopsin-like—HTR2A—migraine	5.28e-05	0.000565	CbGpPWpGaD
Methamphetamine—ADRA2B—GPCR ligand binding—HTR7—migraine	5.27e-05	0.000563	CbGpPWpGaD
Methamphetamine—ADRA2C—GPCR ligand binding—CALCA—migraine	5.26e-05	0.000562	CbGpPWpGaD
Methamphetamine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—HTR7—migraine	5.25e-05	0.000561	CbGpPWpGaD
Methamphetamine—ADRA2C—GPCR downstream signaling—HTR2B—migraine	5.24e-05	0.00056	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling by GPCR—HTR1D—migraine	5.12e-05	0.000547	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling by GPCR—HTR2B—migraine	5.09e-05	0.000545	CbGpPWpGaD
Methamphetamine—SLC6A4—SIDS Susceptibility Pathways—TNF—migraine	5.04e-05	0.000539	CbGpPWpGaD
Methamphetamine—TAAR1—Signaling Pathways—TGFBR2—migraine	5e-05	0.000534	CbGpPWpGaD
Methamphetamine—ADRA2C—GPCR ligand binding—HTR7—migraine	4.92e-05	0.000526	CbGpPWpGaD
Methamphetamine—ADRA2A—GPCR ligand binding—HTR1B—migraine	4.91e-05	0.000525	CbGpPWpGaD
Methamphetamine—ADRA2B—Class A/1 (Rhodopsin-like receptors)—HTR2A—migraine	4.84e-05	0.000518	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling by GPCR—HTR2B—migraine	4.76e-05	0.000509	CbGpPWpGaD
Methamphetamine—ADRA2A—GPCR ligand binding—HTR1A—migraine	4.72e-05	0.000505	CbGpPWpGaD
Methamphetamine—ADRA2A—GPCR ligand binding—NPS—migraine	4.65e-05	0.000497	CbGpPWpGaD
Methamphetamine—ADRA2A—GPCR ligand binding—TAC1—migraine	4.65e-05	0.000497	CbGpPWpGaD
Methamphetamine—MAOA—Metabolism—CACNA1A—migraine	4.58e-05	0.00049	CbGpPWpGaD
Methamphetamine—ADRA2A—GPCR downstream signaling—HTR1D—migraine	4.58e-05	0.000489	CbGpPWpGaD
Methamphetamine—ADRA2A—GPCR ligand binding—HTR2C—migraine	4.56e-05	0.000488	CbGpPWpGaD
Methamphetamine—ADRA2C—Class A/1 (Rhodopsin-like receptors)—HTR2A—migraine	4.52e-05	0.000484	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—CALCRL—migraine	4.45e-05	0.000476	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—RAMP1—migraine	4.45e-05	0.000476	CbGpPWpGaD
Methamphetamine—ADRA2A—GPCR ligand binding—EDNRA—migraine	4.44e-05	0.000475	CbGpPWpGaD
Methamphetamine—ADRA2A—GPCRs, Class A Rhodopsin-like—HTR2A—migraine	4.29e-05	0.000459	CbGpPWpGaD
Methamphetamine—ADRA2A—GPCR ligand binding—CALCA—migraine	4.27e-05	0.000457	CbGpPWpGaD
Methamphetamine—ADRA2A—GPCR downstream signaling—HTR2B—migraine	4.26e-05	0.000455	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—RAMP1—migraine	4.16e-05	0.000445	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—CALCRL—migraine	4.16e-05	0.000445	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—HTR1D—migraine	4.16e-05	0.000444	CbGpPWpGaD
Methamphetamine—MAOA—SIDS Susceptibility Pathways—TNF—migraine	4.13e-05	0.000442	CbGpPWpGaD
Methamphetamine—TAAR1—Signaling Pathways—HTR2A—migraine	4.06e-05	0.000435	CbGpPWpGaD
Methamphetamine—ADRA2A—GPCR ligand binding—HTR7—migraine	4e-05	0.000427	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—HTR2B—migraine	3.86e-05	0.000413	CbGpPWpGaD
Methamphetamine—ADRA2C—Metabolism—CACNA1A—migraine	3.77e-05	0.000403	CbGpPWpGaD
Methamphetamine—ADRA2B—GPCR ligand binding—HTR2A—migraine	3.69e-05	0.000394	CbGpPWpGaD
Methamphetamine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—HTR2A—migraine	3.68e-05	0.000393	CbGpPWpGaD
Methamphetamine—ADRA2B—GPCR downstream signaling—HTR1B—migraine	3.66e-05	0.000391	CbGpPWpGaD
Methamphetamine—TAAR1—Signaling Pathways—ESR1—migraine	3.61e-05	0.000386	CbGpPWpGaD
Methamphetamine—ADRA2B—GPCR downstream signaling—HTR1A—migraine	3.52e-05	0.000376	CbGpPWpGaD
Methamphetamine—ADRA2B—GPCR downstream signaling—TAC1—migraine	3.47e-05	0.00037	CbGpPWpGaD
Methamphetamine—ADRA2B—GPCR downstream signaling—NPS—migraine	3.47e-05	0.00037	CbGpPWpGaD
Methamphetamine—ADRA2C—GPCR ligand binding—HTR2A—migraine	3.45e-05	0.000368	CbGpPWpGaD
Methamphetamine—ADRA2C—GPCR downstream signaling—HTR1B—migraine	3.41e-05	0.000365	CbGpPWpGaD
Methamphetamine—ADRA2B—GPCR downstream signaling—HTR2C—migraine	3.4e-05	0.000363	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—CALCRL—migraine	3.38e-05	0.000361	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—RAMP1—migraine	3.38e-05	0.000361	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling by GPCR—HTR1B—migraine	3.32e-05	0.000355	CbGpPWpGaD
Methamphetamine—ADRA2B—GPCR downstream signaling—EDNRA—migraine	3.31e-05	0.000353	CbGpPWpGaD
Methamphetamine—ADRA2C—GPCR downstream signaling—HTR1A—migraine	3.29e-05	0.000351	CbGpPWpGaD
Methamphetamine—ADRA2C—GPCR downstream signaling—TAC1—migraine	3.24e-05	0.000346	CbGpPWpGaD
Methamphetamine—ADRA2C—GPCR downstream signaling—NPS—migraine	3.24e-05	0.000346	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—HTR1D—migraine	3.24e-05	0.000346	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling by GPCR—HTR1A—migraine	3.2e-05	0.000342	CbGpPWpGaD
Methamphetamine—ADRA2B—GPCR downstream signaling—CALCA—migraine	3.18e-05	0.00034	CbGpPWpGaD
Methamphetamine—ADRA2C—GPCR downstream signaling—HTR2C—migraine	3.17e-05	0.000339	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling by GPCR—TAC1—migraine	3.15e-05	0.000336	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling by GPCR—NPS—migraine	3.15e-05	0.000336	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling by GPCR—HTR1B—migraine	3.1e-05	0.000332	CbGpPWpGaD
Methamphetamine—ADRA2C—GPCR downstream signaling—EDNRA—migraine	3.09e-05	0.00033	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling by GPCR—HTR2C—migraine	3.09e-05	0.00033	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—CACNA1A—migraine	3.06e-05	0.000328	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—HTR1D—migraine	3.02e-05	0.000323	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—HTR2B—migraine	3.01e-05	0.000322	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling by GPCR—EDNRA—migraine	3e-05	0.000321	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling by GPCR—HTR1A—migraine	2.98e-05	0.000319	CbGpPWpGaD
Methamphetamine—ADRA2B—GPCR downstream signaling—HTR7—migraine	2.98e-05	0.000318	CbGpPWpGaD
Methamphetamine—ADRA2C—GPCR downstream signaling—CALCA—migraine	2.97e-05	0.000318	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling by GPCR—TAC1—migraine	2.94e-05	0.000314	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling by GPCR—NPS—migraine	2.94e-05	0.000314	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling by GPCR—CALCA—migraine	2.89e-05	0.000309	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling by GPCR—HTR2C—migraine	2.88e-05	0.000308	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—HTR2B—migraine	2.81e-05	0.0003	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling by GPCR—EDNRA—migraine	2.8e-05	0.0003	CbGpPWpGaD
Methamphetamine—ADRA2A—GPCR ligand binding—HTR2A—migraine	2.8e-05	0.000299	CbGpPWpGaD
Methamphetamine—ADRA2C—GPCR downstream signaling—HTR7—migraine	2.78e-05	0.000297	CbGpPWpGaD
Methamphetamine—ADRA2A—GPCR downstream signaling—HTR1B—migraine	2.77e-05	0.000297	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling by GPCR—HTR7—migraine	2.7e-05	0.000289	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling by GPCR—CALCA—migraine	2.7e-05	0.000289	CbGpPWpGaD
Methamphetamine—ADRA2A—GPCR downstream signaling—HTR1A—migraine	2.67e-05	0.000285	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—LRP1—migraine	2.65e-05	0.000283	CbGpPWpGaD
Methamphetamine—ADRA2A—GPCR downstream signaling—NPS—migraine	2.63e-05	0.000281	CbGpPWpGaD
Methamphetamine—ADRA2A—GPCR downstream signaling—TAC1—migraine	2.63e-05	0.000281	CbGpPWpGaD
Methamphetamine—ADRA2A—GPCR downstream signaling—HTR2C—migraine	2.58e-05	0.000276	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling by GPCR—HTR7—migraine	2.52e-05	0.00027	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—HTR1B—migraine	2.52e-05	0.000269	CbGpPWpGaD
Methamphetamine—ADRA2A—GPCR downstream signaling—EDNRA—migraine	2.51e-05	0.000268	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—LRP1—migraine	2.47e-05	0.000265	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—HTR1D—migraine	2.46e-05	0.000263	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—HTR1A—migraine	2.42e-05	0.000259	CbGpPWpGaD
Methamphetamine—MAOB—Metabolism—MTHFR—migraine	2.42e-05	0.000258	CbGpPWpGaD
Methamphetamine—ADRA2A—GPCR downstream signaling—CALCA—migraine	2.41e-05	0.000258	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—NPS—migraine	2.39e-05	0.000255	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—TAC1—migraine	2.39e-05	0.000255	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—HTR2C—migraine	2.34e-05	0.00025	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—HTR2B—migraine	2.28e-05	0.000244	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—EDNRA—migraine	2.28e-05	0.000244	CbGpPWpGaD
Methamphetamine—ADRA2A—GPCR downstream signaling—HTR7—migraine	2.26e-05	0.000241	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—CALCA—migraine	2.19e-05	0.000234	CbGpPWpGaD
Methamphetamine—ADRA2B—GPCR downstream signaling—HTR2A—migraine	2.08e-05	0.000223	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—HTR7—migraine	2.05e-05	0.000219	CbGpPWpGaD
Methamphetamine—SLC22A3—Metabolism—MTHFR—migraine	2.04e-05	0.000219	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—NOTCH4—migraine	2.03e-05	0.000217	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—LRP1—migraine	2.01e-05	0.000215	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—CACNA1A—migraine	2e-05	0.000213	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—HTR1B—migraine	1.96e-05	0.00021	CbGpPWpGaD
Methamphetamine—ADRA2C—GPCR downstream signaling—HTR2A—migraine	1.95e-05	0.000208	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—NOTCH4—migraine	1.9e-05	0.000203	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling by GPCR—HTR2A—migraine	1.89e-05	0.000202	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—HTR1A—migraine	1.89e-05	0.000202	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—PGR—migraine	1.86e-05	0.000199	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—NPS—migraine	1.86e-05	0.000199	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—TAC1—migraine	1.86e-05	0.000199	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—HTR1B—migraine	1.83e-05	0.000196	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—HTR2C—migraine	1.82e-05	0.000195	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—EDNRA—migraine	1.77e-05	0.00019	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling by GPCR—HTR2A—migraine	1.77e-05	0.000189	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—HTR1A—migraine	1.76e-05	0.000189	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—PGR—migraine	1.74e-05	0.000186	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—NPS—migraine	1.74e-05	0.000186	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—TAC1—migraine	1.74e-05	0.000186	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—NOTCH3—migraine	1.73e-05	0.000185	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—CALCA—migraine	1.71e-05	0.000183	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—HTR2C—migraine	1.7e-05	0.000182	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—EDNRA—migraine	1.66e-05	0.000177	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—NOTCH3—migraine	1.61e-05	0.000173	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—HTR7—migraine	1.6e-05	0.000171	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—CALCA—migraine	1.59e-05	0.00017	CbGpPWpGaD
Methamphetamine—ADRA2A—GPCR downstream signaling—HTR2A—migraine	1.58e-05	0.000169	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—NOTCH4—migraine	1.54e-05	0.000165	CbGpPWpGaD
Methamphetamine—MAOA—Metabolism—MTHFR—migraine	1.52e-05	0.000162	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—HTR7—migraine	1.49e-05	0.000159	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—HTR1B—migraine	1.49e-05	0.000159	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—HTR2A—migraine	1.44e-05	0.000154	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—HTR1A—migraine	1.43e-05	0.000153	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—NPS—migraine	1.41e-05	0.000151	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—PGR—migraine	1.41e-05	0.000151	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—TAC1—migraine	1.41e-05	0.000151	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—HTR2C—migraine	1.38e-05	0.000148	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—TGFBR2—migraine	1.38e-05	0.000147	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—EDNRA—migraine	1.35e-05	0.000144	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—NOTCH3—migraine	1.31e-05	0.00014	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—CALCA—migraine	1.3e-05	0.000138	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—TGFBR2—migraine	1.28e-05	0.000137	CbGpPWpGaD
Methamphetamine—ADRA2C—Metabolism—MTHFR—migraine	1.25e-05	0.000133	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—HTR7—migraine	1.21e-05	0.00013	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—HTR2A—migraine	1.12e-05	0.00012	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—HTR2A—migraine	1.04e-05	0.000112	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—TGFBR2—migraine	1.04e-05	0.000112	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—MTHFR—migraine	1.01e-05	0.000108	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—ESR1—migraine	9.93e-06	0.000106	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—ESR1—migraine	9.27e-06	9.91e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—HTR2A—migraine	8.48e-06	9.07e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—ESR1—migraine	7.53e-06	8.05e-05	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—MTHFR—migraine	6.6e-06	7.06e-05	CbGpPWpGaD
